Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

9800	Companies
196490	Keywords
127485	Articles
104455	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 12/07/2025 at 09:05, 1 month 28 days ago

Onco-Innovations prévoit une cotation croisée au Nasdaq et une possible offre d'actions.

Financement Par Actions Banque D'investissement Recherche Sur Le Cancer Onco-Innovations Cotation Croisée Au Nasdaq
PRESS RELEASE

published on 12/07/2025 at 09:00, 1 month 28 days ago

Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Onco-Innovations engages U.S. investment bank for potential Nasdaq cross-listing and equity financing, part of long-term corporate development strategy

Equity Financing Nasdaq Investment Bank Onco-Innovations Cross-listing
BRIEF

published on 11/25/2025 at 22:35, 2 months 8 days ago

Onco-Innovations participe aux prix d'innovation de l'Université de l'Alberta

Prix De L'innovation Recherche Sur Le Cancer Onco-Innovations Technologie PNKP Université De L'Alberta
BRIEF

published on 11/25/2025 at 22:35, 2 months 8 days ago

Onco-Innovations Engages in University of Alberta's Innovation Awards

Cancer Research Innovation Awards Onco-Innovations PNKP Technology University Of Alberta
PRESS RELEASE

published on 11/25/2025 at 22:30, 2 months 8 days ago

Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
Onco-Innovations recognized at University of Alberta's 2025 Innovation Awards for advancing oncology innovation and commercializing PNKP Inhibitor Technology from university research

Innovation Awards Cancer Therapeutics Onco-Innovations University Of Alberta PNKP Inhibitor Technology
BRIEF

published on 11/21/2025 at 01:35, 2 months 13 days ago

Onco-Innovations Advances PNKP Inhibitor Scale-Up with Dalton Partnership

Cancer Treatment Clinical Studies Dalton Pharma Services PNKP Inhibitor Manufacturing Optimization
BRIEF

published on 11/21/2025 at 01:35, 2 months 13 days ago

Onco-Innovations accélère la production d'inhibiteurs de PNKP grâce à un partenariat avec Dalton.

Traitement Du Cancer Études Cliniques Optimisation De La Production Services Pharmaceutiques Dalton Inhibiteur De PNKP
PRESS RELEASE

published on 11/21/2025 at 01:30, 2 months 13 days ago

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
Onco-Innovations partners with Dalton Pharma Services for A83B4C63 manufacturing optimization and scale-up activities, aiming for future clinical material production

Onco-Innovations Dalton Pharma Services Manufacturing Optimization Scale-up Activities Clinical Material Production
BRIEF

published on 11/19/2025 at 00:05, 2 months 15 days ago

Onco-Innovations et Kuano collaborent au développement d'un inhibiteur de PNKP

L'IA Dans La Découverte De Médicaments Onco-Innovations Inhibiteur De PNKP Kuano Analyse Quantique
BRIEF

published on 11/19/2025 at 00:05, 2 months 15 days ago

Onco-Innovations and Kuano Collaborate on PNKP Inhibitor Development

AI In Drug Discovery Onco-Innovations PNKP Inhibitor Kuano Quantum Analytics

Accesswire

Published on 02/04/2026 at 02:15, 9 hours 13 minutes ago

Future Fuels Announces $2 Million LIFE Flow-Through Offering
Published on 02/04/2026 at 00:00, 11 hours 28 minutes ago

Sintana Energy Inc. Announces VMM-37 Resolution
Published on 02/03/2026 at 23:30, 11 hours 58 minutes ago

FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 12 hours 16 minutes ago

Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 12 hours 58 minutes ago

Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 11:07, 21 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 02/04/2026 at 11:05, 23 minutes ago

AUSTRIACARD Successfully Achieves mada Card Chip Profile Certification
Published on 02/04/2026 at 11:03, 25 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 02/04/2026 at 10:56, 32 minutes ago

Conference call on the results for the 1st quarter 2025/2026 (ending 31 December 2025) on 11 February 2026
Published on 02/04/2026 at 10:52, 36 minutes ago

EQS-Adhoc: Limes Schlosskliniken AG: Preliminary group result (unaudited) / forecast 2026

Les Echos

Published on 02/03/2026 at 19:18, 16 hours 10 minutes ago

Paulic Meunerie - Chiffre d'Affaires 2025
Published on 02/03/2026 at 18:00, 17 hours 28 minutes ago

Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 17 hours 43 minutes ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 17 hours 43 minutes ago

Revenue growth in 2025 to €11.2m (+5%)
Published on 02/03/2026 at 17:45, 17 hours 43 minutes ago

Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)

View all LES ECHOS COMFI WIRE